These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1130257)

  • 1. Letter: Opposition to MAC.
    Dougherty RL
    Am Fam Physician; 1975 Jun; 11(6):31-4. PubMed ID: 1130257
    [No Abstract]   [Full Text] [Related]  

  • 2. MAC--a cutting tool for federal reimbursements on prescription drugs?
    Hirsh HL
    J Leg Med (N Y); 1976 Feb; 4(2):31-3. PubMed ID: 1082483
    [No Abstract]   [Full Text] [Related]  

  • 3. Holding down prescription drug costs.
    FDA Consum; 1975 Dec-1976 Jan; 9(10):9-10. PubMed ID: 10305011
    [No Abstract]   [Full Text] [Related]  

  • 4. How to pay less for prescription drugs.
    Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036
    [No Abstract]   [Full Text] [Related]  

  • 5. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy implications of MAC: AWP-AAC differentials among pharmacies.
    Norwood GJ; Lipson DP; Freeman RA
    J Am Pharm Assoc; 1977 Aug; 17(8):496-9. PubMed ID: 893916
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug economics and the elderly: prescriptions for change.
    Lipton HL
    Bus Health; 1988 Mar; 5(5):8-11. PubMed ID: 10312402
    [No Abstract]   [Full Text] [Related]  

  • 8. An assessment of prescription dispensing costs and related factors.
    Herman CM; Zabloski EJ
    Med Care Rev; 1978 Aug; 35(8):835-80. PubMed ID: 10297221
    [No Abstract]   [Full Text] [Related]  

  • 9. The Maximum Allowable Cost program--some marketing consequences.
    Gosselin RA
    Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies for managing prescription drug costs.
    Stern L
    Bus Health; 1990 Jun; 8(6):41-2, 44. PubMed ID: 10104793
    [No Abstract]   [Full Text] [Related]  

  • 11. Economizing with psychotropic drugs.
    Sider RC
    Prim Care; 1976 Mar; 3(1):137-43. PubMed ID: 7793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economics of drug prescribing in Ireland.
    O'Hanrahan M; O'Malley K
    Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug cost changes.
    Deibel AW
    J Psychiatr Nurs Ment Health Serv; 1976 Feb; 14(2):39-40. PubMed ID: 175160
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of wholesale discounts and other factors on prescription ingredient costs.
    Gagnon JP; Rodowskas CA
    Am J Public Health; 1974 Oct; 64(10):969-76. PubMed ID: 4416324
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost of medicine.
    Silk AD
    West J Med; 1990 Jan; 152(1):75-6. PubMed ID: 2309481
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost of prescription drugs.
    Med Lett Drugs Ther; 1975 Jan; 17(2):5-6. PubMed ID: 803295
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: generic prescriptions: can the consumer benefit?
    Gumbhir AK; Rodowskas CA
    Ann Intern Med; 1975 May; 82(5):711-12. PubMed ID: 1137267
    [No Abstract]   [Full Text] [Related]  

  • 18. Pills, prunes and perils.
    White EV
    J Am Pharm Assoc; 1975 Mar; 15(3):151-5. PubMed ID: 1127203
    [No Abstract]   [Full Text] [Related]  

  • 19. The generic prescribing issue.
    Brater DC; Pettinger WA
    Ann Intern Med; 1980 Mar; 92(3):426-7. PubMed ID: 7356238
    [No Abstract]   [Full Text] [Related]  

  • 20. Survey shows hospitals expand generic drug use.
    Jaffe MO
    Health Care Week; 1979 Feb; 2(30):1, 3. PubMed ID: 10240113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.